Oral cancer therapy is taken at home. The support around it should not stop at your office door.
Oral oncolytics like lenalidomide and Ibrance are taken at home, where prior authorizations, REMS enrollment, cost, and side effects all sit on the patient. Fairview Pharmacy dispenses locally, handles the REMS and PA process, navigates financial assistance, and verifies cycle adherence, so the therapy you prescribe stays supported.
What the patient is carrying at home
Once an oral oncolytic leaves your office, the logistics become the patient's problem.
An oral oncolytic can carry a REMS enrollment requirement, a prior authorization that takes time to clear, an out of pocket cost that stops a patient cold, and a dosing schedule managed alone at home. When the prescription is routed to a distant mail order pharmacy, you lose visibility into all of it.
Fairview dispenses locally and stays involved: REMS enrollment handled, prior authorization worked, financial assistance navigated, and contact maintained with the patient through each cycle.
What a specialty capable pharmacy does
REMS, prior authorization, financial navigation, cycle verification.
REMS and prior authorization
We manage REMS enrollment and the prior authorization process for oral oncolytics, so the workload does not sit on your staff and the patient does not wait longer than necessary.
Financial toxicity support
We help patients identify and apply for manufacturer copay assistance and foundation grants, so cost is less likely to interrupt therapy.
Cycle adherence verification
We confirm each treatment cycle is started and completed, and we synchronize refills so the schedule holds.
Side effect check ins
We call between refills to catch nausea, fatigue, and other side effects early, before they become a reason to stop.
Communication back to you
We flag adherence concerns and barriers back to your office, so you are not the last to know when a patient is struggling to stay on therapy.
This page describes pharmacy services: REMS, prior authorization, financial navigation, and adherence support. The clinical care is yours; the medication logistics are where Fairview helps.
The visibility you lose
When an oral oncolytic is routed to a distant mail order pharmacy, you lose visibility.
Nobody confirms the patient started. Nobody catches a skipped cycle. Nobody calls when cost has become the reason they stopped. The patient may never tell you; they just fall off therapy quietly.
A local, specialty capable pharmacy closes that gap. Fairview dispenses here, in Hattiesburg, and stays in contact through every cycle.
EQuIPP verified, 5 star, 4 years running
Fairview is a measured, high performing pharmacy. We bring that rigor to oncology support.
Fairview performs in the 93rd percentile nationally on the EQuIPP quality platform.
Fairview Pharmacy ranks in the 93rd percentile nationally for medication adherence and holds a 5 star rating, 4 years running, with verified EQuIPP performance from 95.6% to 98.2% across our measured adherence categories. We apply the same rigor to oral oncolytic support: REMS and prior authorization worked promptly, financial barriers navigated, every cycle verified, contact maintained.
EQuIPP performance metrics as of Quarter 4, 2025. Source: Pharmacy Quality Solutions EQuIPP platform.
You prescribe.
E prescribe to Fairview. NCPDP 2515104, NPI 1144383613.
We fill and enroll.
We handle REMS enrollment and the prior authorization.
We verify each cycle.
We confirm each cycle is started and completed, and call between refills.
We report to you.
Adherence and cycle updates on the patients you referred.
You reinforce.
You address adherence at the next visit, informed by what actually happened at home.
Local same day dispensing
Oral oncolytics filled here, not mailed from out of state.
100% PA and REMS handling
We manage every prior authorization and REMS enrollment for you.
Cycle adherence verification
We confirm every treatment cycle is started and completed.
Financial toxicity support
We find copay assistance and foundation grants before cost interrupts therapy.
Side effect check ins
We call between refills to catch side effects early.
Adherence reports to you
Cycle by cycle adherence delivered to your office.
Start with 5, zero risk
Send us 5 of your patients on oral oncolytics. 90 days. Zero risk.
We handle the REMS and prior authorizations, verify every cycle, and report adherence back to your office. If you do not see better consistency, you owe us nothing. No long term contracts. No commitments. Just results.
Request your intro call
A 10 minute call with Dr. Mike, no commitment and no paperwork to start. Just tell us how to reach you and a little about your practice. The 5 patient pilot is what we walk through on the call.
Typical response: Within 1 business day